Recruiting Advanced Solid Tumors Studies in Shanghai
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
This study will evaluate the safety, tolerability, and efficacy of DS-3939a in participants with advanced solid tumors....
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
This pan-tumor trial is designed as a signal-seeking trial to assess efficacy and safety of raludotatug deruxtecan (R-DXd) monotherapy in locally advanced or metastatic solid tumors with various cadhe...
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
This is a Phase 1/2a first-in-human, multi-center, non-randomized, open-label study to assess the safety, tolerability, pharmacokinetics profile, and preliminary anti-tumor activity of IPG7236 adminis...
Study for AZD4360 in Participants With Advanced Solid Tumours
The purpose of this study is to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary efficacy of AZD4360 in adult participants with locally advanced or metastatic s...
A Study of ZL-1310 in Participants With Selected Solid Tumors
A Phase Ib/II, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors...
Study of SGN1 in Patients With Advanced Solid Tumor
Objectives:To assess the safety and tolerability followed by a dose expansion study to characterize safety, and preliminary efficacy of SGN1 in participants with refractory solid tumors. Study Ration...
About Advanced Solid Tumors Clinical Trials in Shanghai
Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.
There are currently 6 advanced solid tumors clinical trials recruiting participants in Shanghai, SHANGHAI%20MUNICIPALITY. These studies are seeking a combined 1,139 participants. Research is being sponsored by Daiichi Sankyo, Nanjing Immunophage Biotech Co., Ltd, AstraZeneca and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Advanced Solid Tumors Clinical Trials in Shanghai — FAQ
Are there advanced solid tumors clinical trials in Shanghai?
Yes, there are 6 advanced solid tumors clinical trials currently recruiting in Shanghai, SHANGHAI%20MUNICIPALITY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Shanghai?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Shanghai research site will contact you about next steps.
Are clinical trials in Shanghai free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Shanghai studies also compensate for your time and travel.
What advanced solid tumors treatments are being tested?
The 6 active trials in Shanghai are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.
Data updated March 2, 2026 from ClinicalTrials.gov